CBUS cibus.com: חוב לטווח קצר להון עצמי

The daily price chart for Cibus, Inc. (CBUS) helps assess the effectiveness of its gene modification licensing model, which reduces costs and generates a stable cash flow, reaching the value of 1.01. However, success depends on overcoming regulatory hurdles and the adoption of new crops by farmers. Management is currently focusing on transitioning from research to mass sales, while maintaining strong market confidence in its capabilities.

This indicator compares liabilities with a maturity of over one year against total equity to determine the company's degree of dependence on short-term debt financing. An analysis of the short-term financial leverage ratio allows for an assessment of how sustainably Cibus, Inc. (CBUS) is scaling plant gene editing through partnerships to avoid underfunding risks while developing drought-resistant crops over the long term.